What Does This “Government Shutdown” Mean for HIV/AIDS Drugs?
Turns out it’s not so good. With Congress locked in a critical battle over fiscal talks, the looming threat of a government shutdown on October 1 (tomorrow!) may spell potential delays in FDA approvals of new drugs, such as Viiv’s Tivicay and Epzicom as well as the Hep C pharma field.
Treatment News: Women Spontaneously Clear Hep C Better Than Men
Spontaneous clearance of acute hepatitis C virus (HCV)—when viral levels drop to undetectable without drug treatment during the early phase of infection—is twice as likely to occur in women than in men.
David Kwiatkowski stole painkiller syringes and injected himself with them, which tainted them with hep C. He then filled them with saline and put them back for medical use.
National Hepatitis Awareness Month 2013
According to the Centers for Disease Control and Prevention (CDC), more than 4 million Americans are living with chronic hepatitis B or hepatitis C and more than 15,000 die each year from liver cancer or diseases associated with the infections. Most do not know they have the virus.
To read more, click here.
The Hepatitis C Drug Pipeline Report: A Groundswell to Become a Sea Change
Frantic competition between the major pharmaceutical players has accelerated progress to a breakneck speed. Scientists are charged with excitement over the promise of a new paradigm in hep C treatment: Simplified, all-oral, interferon-free therapies with high cure rates for broad swaths of the hep C population.
Herbology v. hepatitis
POZ Blogger, Mike Barr tries out Chinese herbal formulas for liver health in his most recent post.
Bee Venom: The Next Anti-HIV Agent?
Nanoparticles filled with a toxin called melittin that’s found in bee venom can destroy HIV and have a benign effect on surrounding cells.
To read more, Click here.
Baby Boomers - To Test or Not to Test - That is the Question!
Given that screening for hepatitis C involves a simple, inexpensive blood test, I would like to offer my own recommendations as a person who actually has hepatitis C.
Read more of Margaret Dudley’s blog: http://blogs.hepmag.com/margaretdudley/2012/12/testing_baby_boomers_hepc.html
Hepatitis C in the U.S. May Be Underestimated by Over a Million
In the United States, the number of people who have been infected with hepatitis C virus (HCV) may have been undercounted by a whopping 1.1 million. Epidemiologists believe that at least 5.2 million people in the United States are HCV antibody positive—meaning that they were infected at one time, although they may not have developed chronic hepatitis C—an increase of 1.1 million over The National Health and Nutrition Examination Survey (NHANES) estimate of 4.1 million cases. Click here for more.